USP通知事項

2024年8月

開発中の標準品の情報です。
Catalog #Description

1342117

Insulin Human (10 mg)

1441276

Metoprolol Related Compound E

1443249

Metyrosine R-Enantiomer

1581796

Punicalagin (10 mg)

1609862

Saxagliptin

1705500

Undecanedioic Acid

1718111

Vortioxetine Related Compound G (15 mg) (1-{2-[(2,6-Dimethylphenyl)thio]phenyl}piperazine hydrobromide)

1718122

Vortioxetine Related Compound H

1718133

Vortioxetine Related Compound I

USP通知事項

2024年8月

新しい標準品の情報です。
Catalog #Description

ロット*No New USP RS's Released in July 2024*

発売日USP通知事項

2024年8月

新しいロットの情報です。
Catalog #Description

1081750

1,4-Butanedisulfonic Acid (120 mg)

10257371029512Aminolevulinic Acid Related Compound B (25 mg) (Methyl 5-(1,3-dioxoisoindolin-2-yl)-4oxopentanoate)
Amlodipine Related Compound A (25 mg) (3-Ethyl 5-methyl [2-(2-aminoethoxymethyl)-4(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate] fumarate)

現行ロット

旧ロット

（新ロット）

有効期限(年/月)

R195G0F132S0 (2025/7)

R23780F01800 (2025/2)

R192B0R10140 (2025/8)
G0G291 (2025/7)

1029909

Ammonio Methacrylate Copolymer Type A (100 mg)

R184C01356676

Anhydrous Lactose (100 mg) (A Mixture of alpha and beta anomers)

R184G0

R043D0 (2025/7)

1043331

Asiaticoside (30 mg)

R115M1

R115M0 (2025/7)

F133F1

F133F0 (2025/7)

R18960R106Y0 (2025/7)

10435241078529

Asparagine Related Compound A (10 mg) (2,2'-(3,6-dioxopiperazine-2,5diyl)diacetamide)
Bupivacaine Related Compound B (50 mg) N-(2,6-Dimethylphenyl)piperidine-2carboxamide Hydrochloride

1081501

Butamben (200 mg)

R23370

H1K373 (2025/2)

1082956

Butane-1,3-diol (1 mL)

R22030R175E0 (2025/6)

F03431

F03430 (2025/7)

Candesartan Cilexetil Related Compound D (10 mg) (11087847{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate)1131960

Cholesterol (125 mg)

R19500R112K0 (2025/8)

1133897

Cinnamaldehyde (100 mg)

R195C0F057Q0 (2025/7)

R20710F078S0 (2025/7)

R204A0

R014S0 (2025/7)

R213M0F05410 (2025/7)

R18620F0M219 (2025/7)

R212Q0R08200 (2025/6)

R220A0F0H428 (2025/4)

11380191140597
115032012060171227006
1231660

Clindamycin Phosphate System Suitability (Clindamycin phosphate containing 7Epiclindamycin phosphate) (2.2 mg)
Clopidogrel Related Compound B (20 mg) (Methyl(+/-)-(o-chlorophenyl)-4,5dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride)
Creatine (200 mg)
Dimenhydrinate Related Compound E (15 mg) (8-chloro-3,7-dihydro-1,3,7-trimethyl-1Hpurine-2,6-dione)
Doxylamine Succinate (300 mg)
Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid)1265515Ethylene Glycol (0.5 mL)

R211M0

R093Q0 (2025/7)

1269356

Febantel (200 mg)

R16480F033H0 (2025/8)

1270708

Flavoxate Hydrochloride (200 mg)

R195Y0F0H157 (2025/7)

1272929

Fludeoxyglucose Related Compound B (10 mg) (2-chloro-2-deoxy-D-glucose)

R215Y0F0H343 (2022/10)

R213U0F143K0 (2025/4)

Fosamprenavir Related Compound A (10 mg) (Calcium (6R,7S,16S,17R)-4,19-bis[(41283379

aminophenyl)sulfonyl]-7,16-dibenzyl-2,21-dimethyl-9,14-dioxo-10,13-dioxa-4,8,15,19tetraazadocosane-6,17-diyl bis(phosphate))

1287030

Furosemide Related Compound B (100 mg) (4-Chloro-5-sulfamoylanthranilic Acid)

R19810R00750 (2025/7)

1288463

Gemcitabine Hydrochloride (200 mg)

R18860

R094H0 (2025/7)

1294036

Glucagon (HUMAN) (2 x 2.94 mg) (COLD SHIPMENT REQUIRED)R213D0

R12871 (2025/5)

1329800

Hydroxypropyl Cellulose (500 mg)

R19390R14780 (2025/6)

1193356

Iscotrizinol (100 mg)

R213C0F024R0 (2025/7)

1353500

Isotretinoin (200 mg)

R213X0

R09860 (2025/7)

1354309

Ivermectin (200 mg)

R190K0

R091C0 (2025/6)

1374226

Magnesium Carbonate (2 g)

R204Y0R12291 (2024/12)

1378001

Medroxyprogesterone Acetate (200 mg)

R209E0

R032M1 (2025/7)

1733119

Meso-Zeaxanthin (5x 30 mg)

R184A0F0K295 (2024/9)

1446000

Monoglycerides (125 mg)

R214B0

H1D232 (2025/3)

R198B0

R080N0 (2025/7)
R065N0 (2025/7)

Moxifloxacin Related Compound G (15 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-81448672

methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3quinolinecarboxylic acid, monohydrochloride)1478505

Omeprazole (200 mg)

R195801500353

Paroxetine System Suitability Mixture A (50 mg)

R18380

R068A0 (2025/6)

1500502

Particle Count Set (2 blanks (28 mL each) and 2 suspensions (25 mL each))

R211H0

R182N0 (2025/7)

1549840

Potassium Bitartrate (3 g)

R19640F0D384 (2025/7)

1548280

Potassium Iodide (1 g)

R189L0R030W0 (2025/7)

1565009

Procarbazine Hydrochloride (200 mg)

R203P0F2K338 (2025/7)

1586020

Pyridostigmine Related Compound A (50 mg) (Pyridin-3-yl dimethylcarbamate)R19420F1M348 (2025/5)

R19780R06090 (2025/7)

Sumatriptan Succinate Related Compound A (15 mg) ([3-[2-(Dimethylamino)ethyl]-21642212[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-Nmethylmethanesulfonamide succinate salt)

1680608

Tributyl Citrate (500 mg)

R018F1

R018F0 (2025/7)

1708650

Valproic Acid Related Compound K (25 mg) (2-Ethyl-2-methylpentanoic acid)

R188V0

F150P0 (2025/3)

USP通知事項

171802017250032024年8月

Voriconazole Related Compound B (10 mg) ((2S, 3R)-2-(2,4-Difluorophenyl)-3-(5fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
Zonisamide (200 mg)

R19530

R095D0 (2025/7)

R198R0F0J010 (2025/7)

USP通知事項

2024年8月

在庫切れでしたが現在は在庫がございます。
Catalog #Description

ロット

1025737

Aminolevulinic Acid Related Compound B (25 mg) (Methyl 5-(1,3-dioxoisoindolin-2-yl)-4-oxopentanoate)

R237801040774

Apixaban Related Compound F (25 mg) (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1Hpyrazolo[3,4-c]pyridine-3-carboxylate)

F179C11082956

Butane-1,3-diol (1 mL)

R220301265515Ethylene Glycol (0.5 mL)

R211M01272929

Fludeoxyglucose Related Compound B (10 mg) (2-chloro-2-deoxy-D-glucose)

R215Y01294036

Glucagon (HUMAN) (2 x 2.94 mg) (COLD SHIPMENT REQUIRED)R213D01374226

Magnesium Carbonate (2 g)

R204Y01733119

Meso-Zeaxanthin (5x 30 mg)

R184A01446000

Monoglycerides (125 mg)

R214B01586020

Pyridostigmine Related Compound A (50 mg) (Pyridin-3-yl dimethylcarbamate)R194201680608

Tributyl Citrate (500 mg)

R018F1

USP通知事項

2024年8月

入庫待ち製品です。2024年年8月12日時点での入庫予定日です。
Catalog #Description

1201002

17alpha-Dihydroequilin (50 mg) (Estra-1,3,5(10),7-tetraene-3,17alpha-diol)

1011890

Advantame Acid (20 mg) (N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]aspartyl]phenylalanine)

1012655
1039006
1045508
10482881076308
10976141133886

Albuterol Related Compound B (10 mg) (2-(tert-butylamino)-1-[4-hydroxy-3(hydroxymethyl)phenyl]ethanone)
Anthralin (200 mg)
Aurothioglucose (100 mg)
Beta Glucan (1 g)
Bleomycin Sulfate (15 mg)
Cefdinir (300 mg)
Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2-(O,Odiethylphosphonomethoxy)propyl]cytosine hydrochloride)

入庫予定
2024 7月-9月
未定
2024 7月-9月
2024 7月-9月
未定
2024 10月-12月
2024 7月-9月
2024 7月-9月
未定

1134051

Cilastatin Ammonium Salt (100 mg)

2024 7月-9月

1134404

Clavam-2-carboxylate Potassium (2 mg)

2024 10月-12月

1138347

Clobazam Related Compound E (25 mg) (N-[4-Chloro-2-(phenylamino)phenyl]-N-methylacetamide)

1154015

Cyclizine Related Compound A (50 mg) (1-methylpiperazine)

2024 10月-12月

1204102

Dihydroxyacetone (250 mg)

2024 7月-9月

12250221228029

Doxapram Related Compound B (25 mg) (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3diphenylpyrrolidin-2-one, hydrochloride)
Drometrizole Trisiloxane Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-pcresol)

未定

2025 1月-3月
未定

1228053

Drometrizole Trisiloxane Related Compound D (25 mg) (2-(2H-Benzotriazol-2-yl)-6-isobutyl-p-cresol)

1231003

Dydrogesterone (200 mg)

2024 10月-12月

未定

1235004

Emetine Hydrochloride (300 mg)

2024 10月-12月

1268852

Etoposide Resolution Mixture (10 mg)

1269414Fenbendazole Related Compound A (30 mg) (Methyl (1H-benzimidazole-2-yl)carbamate)未定
2024 7月-9月

Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer
1285942([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic

未定acid monosodium salt))
12834591286800
1287518
1287664

Fosinopril Related Compound E (15 mg) ((4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4phenylbutyl)phospinyl]acetyl-L-proline propionate (ester), sodium salt)
Furazolidone (200 mg)
Gadodiamide Related Compound A (25 mg) (Gadolinium sodium diethylenetriamine pentaacetic acidmonomethylamide)
Gadoteridol Related Compound C (50 mg) (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-2024 7月-9月
2024 7月-9月
2024 10月-12月
2024 7月-9月

1303750

diacetic acid)
Hemoglobin Protease Substrate (100 g) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED)

1355753

Kawain (200 mg)

1356945

Lauroyl Arginine (100 mg) (dodecanoylarginine hydrochloride)1374361

Magnesium Sulfate (1 g) (Magnesium Sulfate (1:1) heptahydrate)

2024 7月-9月

1396003

Metaraminol Bitartrate (200 mg)

2024 10月-12月

1414036

Methotrexate Related Compound C (50 mg) ((S)-2-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6yl)methyl](methyl)amino}benzamido) pentanedioic acid)2024 7月-9月
未定
未定

2024 10月-12月

1445481

Monensin Sodium (200 mg)

1453005

Naloxone (200 mg)

2024 10月-12月

1458019

Neomycin B (150 mg)

2024 10月-12月

1460204

Neotame (200 mg)

2024 10月-12月

1546194

Polydatin (20 mg) (3-Hydroxy-5-[(E)-2-(4-hydroxyphenyl)vinyl]phenyl Beta-D-glucopyranoside)

1355709

Powdered Kava Extract (1 g)

1592205

Quazepam CIV (200 mg)

1598020

Rabeprazole Related Compound A (25 mg) (Disodium 1-benzimidazol-2-yl-3-methyl-4-oxo-1,4dihydropyridine-2-carboxylate)未定

未定
2024 7月-9月
未定
2024 7月-9月

1602003

Resorcinol (200 mg)

2024 7月-9月

1643543

Temozolomide (200 mg)

2024 10月-12月

1663700

Thiostrepton (200 mg)

2024 10月-12月

1667359

Tiletamine Hydrochloride (200 mg)

2024 10月-12月

1667439

Tioconazole (200 mg)

1705334

Ubiquinol (5 x 50 mg) (COLD SHIPMENT REQUIRED)
Valacyclovir Related Compound C (10 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-

1707855yl)methoxy]ethyl N-methyl-L-valinate hydrochloride)

1711029

Vardenafil System Suitability (20 mg)

1711461

Verteporfin (200 mg)
Zolmitriptan R-Isomer (20 mg) ((R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-

1727018

one)

未定
2024 10月-12月
2024 7月-9月
未定
2024 7月-9月
2024 7月-9月

USP通知事項

2024年8月

名称あるいは容量に変更があります。
Catalog #ロット

1029909

R184C01356676

R184G0(100 mg)

1138019

R20710100 mgN/AAnisyl Butyrate (5 x 0.5 mL)

2.5 mL

N/A

Anisyl Phenylacetate (5 x 0.5 mL)

2.5 mL

N/A

Cinnamaldehyde (3 x 100 mg)

100 mg

300 mg

2.2 mg

30 mg

100 mg

200 mg

Galactopyranosyl-D-glucopyranose)(DISCONTINUED)
R195C0500 mgAnhydrous Lactose (100 mg) (4-O-beta-D-

Anisyl Phenylacetate (5 x 0.5 mL)

1133897

100 mgAmmonio Methacrylate Copolymer Type A (500 mg)

of alpha and beta anomers)(DISCONTINUED)

1037044

旧容量

旧名称

Anhydrous Lactose (100 mg) (A Mixture

Anisyl Butyrate (5 x 0.5 mL)

1037022

現容量

現名称
Ammonio Methacrylate Copolymer Type A

Cinnamaldehyde (100 mg)
Clindamycin Phosphate System Suitability(Clindamycin phosphate containing 7- Clindamycin Phosphate System Suitability (30 mg)
Epiclindamycin phosphate) (2.2 mg)

1193356

R213C0Iscotrizinol (100 mg)

Iscotrizinol (200 mg)

USP通知事項

2024年8月

以下の標準品の旧ロットは、2024年7月で有効期限が切れます。
Catalog #Description

1001502

Acepromazine Maleate (250 mg)

1012054101188910429291044538

Acyclovir Related Compound F (50 mg) (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9dihydro-1H-purin-2-yl]acetamide)
Advantame (200 mg)
Articaine Related Compound A (40 mg) (Methyl 4-methyl-3-[2(propylamino)acetamido]thiophene-2-carboxylate hydrochloride)
Atorvastatin Related Compound B (20 mg) (Calcium (3S,5R)-7-[2-(4-Fluorophenyl)-5isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2))

現行ロット

旧ロット

（新ロット）

有効期限(年/月)

R22660

R003N0(2024/7)

R190V0F1M502(2024/7)

R187A0F034R0(2024/7)

R19630F0I199(2024/7)

R17490R06230(2024/7)

1048007

Bacitracin Zinc (200 mg)

R175J0

R048C0(2024/7)

1096699

Carprofen (200 mg)

R196F0R025W0(2024/7)

F042Y1

F042Y0(2024/7)

R15810

R072P0(2024/7)

1133886

Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2-(O,Odiethylphosphonomethoxy)propyl]cytosine hydrochloride)1134404

Clavam-2-carboxylate Potassium (2 mg)

1161000

Cyproheptadine Hydrochloride (500 mg)

1164200

Darifenacin Hydrobromide (150 mg)

R16950F04960(2024/7)

1181506

Diacetylated Monoglycerides (200 mg)

R209F0

R024D1(2024/7)

1188006

Dichlorphenamide (200 mg)

R12811

R12810(2024/7)

1225281

Dorzolamide Hydrochloride (200 mg)

R17390R095U0(2024/7)

1268965

Eugenol (5 x 100 mg)

R18440

R045G0(2024/7)

1287664

R144F0(2024/7)

Gadoteridol Related Compound C (50 mg) (1,4,7,10-Tetraaza-11-oxo-

F0B199(2024/7)

bicyclo[8.2.2]tetradecane-4,7-diacetic acid)1324319

Hydroxocobalamin Chloride (3 x 150 mg)

R210Q01667202

L-Threonine (200 mg)

R07941

R07940(2024/7)

1539803

Maritime Pine Extract (1.5 g)

R192X0

R075H0(2024/7)

1396309

Metformin Hydrochloride (200 mg)

R178B0

R069H0(2024/7)

1434011

Methylphenidate Hydrochloride Erythro Isomer Solution (0.5 mL)

G2M060

G1M060(2024/7)

R171N0R116Q0(2024/7)

R16720F0G368(2024/7)

1478593
1491365

Ondansetron Related Compound A (50 mg) (3-[(Dimethylamino)methyl]-9-methyl1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
Paclitaxel Impurity Mixture (10 mg) (This mixture contains paclitaxel and paclitaxel
benzyl analog)

F0M201(2024/7)

1510889

Perindopril Erbumine (100 mg)

R177N0

R068H1(2024/7)

1076206

Powdered Black Cohosh Extract (1.5 g)

R192M0F0D086(2024/7)

1563331

Probucol Related Compound B (25 mg) (4,4'-dithio-bis(2,6-di-tert-butylphenol))F-2(2024/7)(DISCONTINUED)

1576005

Propranolol Hydrochloride (200 mg)

R168F0R031H0(2024/7)

1586009

Pyridostigmine Bromide (200 mg)

R162Q0R05040(2024/7)

1612903

Sitagliptin Phosphate (200 mg)

R17170R07630(2024/7)

1623604

Succinylmonocholine Chloride (50 mg)

R167H0R05600(2024/7)

1642100

Sulisobenzone (500 mg)

R17360R09800(2024/7)

R180U0F0L197(2024/7)

R171A0

R029Y0(2024/7)

1437701
1672206

Terbinafine Related Compound D (25 mg) ((2E)-N,6,6-trimethyl-N-[(4methylnaphthalen-1-yl)methyl]hept-2-en-4-yn-1-amine hydrochloride)
Topiramate (150 mg)

USP通知事項

2024年8月

以下の標準品の旧ロットは、2024年8月で有効期限が切れます。
現行ロット

旧ロット

（新ロット）

有効期限(年/月)

Catalog #Description

1006506

Acetohydroxamic Acid (200 mg)

R198P0

R14960(2024/8)

1012553

Albendazole (200 mg)

R166U0

R110M0(2024/8)

1029013

Amitriptyline Related Compound A (25 mg) (dibenzosuberone)

R187B0

R072Q0(2024/8)

R188J0

R083T0(2024/8)

R180J0F009K0(2024/8)

R16090F067Y0(2024/8)

R183K0R07700(2024/8)

R18270

R062M0(2024/8)

F048G0(2024/8)

1029024104599310670451076374

Amitriptyline Related Compound B (25 mg) (5-[3-(dimethylamino)propyl]-10,11-dihydro5H-dibenzo[a,d]-cyclohepten-5-ol)
Azathioprine Related Compound A (15 mg) (1-Methyl-4-nitro-1H-imidazol-5-amine)
Betamethasone Acetate Related Compound D (20 mg) (9,11Beta-Epoxy-17,21-dihydroxy16Beta-methylpregna-1,4-diene-3,20-dione 21-acetate)
Brinzolamide Related Compound A (50 mg) ((S)-4-(Ethylamino)-2-(3-methoxypropyl)3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide(S)-Isomer))

1134368

Citric Acid (200 mg)

1154649

Cyclohexanecarboxylic Acid (500 mg) (DISCONTINUED)

1096564

D-Carglumic Acid (30 mg) (N-Carbamoyl-D-glutamic acid)

R197F01171819

Desbenzyl Donepezil Hydrochloride (20 mg)

R16971

F0L339(2024/8)

1185020

Diazepam Related Compound A (25 mg) (2-methylamino-5-chlorobenzophenone)

R164J0

R083U0(2024/8)

1204102

Dihydroxyacetone (250 mg)

1233508

Edetic Acid (200 mg)

R148H0

R08860(2024/8)

1279065

Fluorouracil Related Compound F (25 mg) (2-Ethoxy-5-fluoropyrimidin-4(1H)-one)

R18130F0M375(2024/8)

R186L0I0D361(2024/8)
G1L125(2024/8)

1285308

Flurazepam Related Compound C (50 mg) (5-Chloro-2-(2-diethylaminoethylamino)-2'fluorobenzophenone hydrochloride)

F0L384(2024/8)

F(2024/8)

1285909

Fluvoxamine Maleate (200 mg)

R172L01311000

Homatropine Methylbromide (250 mg)

R160C0K0I368(2024/8)

1319002

Hydrocortisone Hemisuccinate (200 mg)

R195P0R05940(2024/8)

R163P0F3L329(2024/8)

R185N0F0I296(2024/8)

F122S1F122S0(2024/8)

R17590F1H290(2024/8)

R108K1

R108K0(2024/8)

1356789
1437202
144971114910151535755

Lamotrigine Related Compound C (10 mg) (3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin5(4H)-one)
Methylpyrrolidone (2 g)Nadolol Related Compound A (25 mg) ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4tetrahydronaphthalene-2,3-diol)
Oxytetracycline Hydrochloride (200 mg)
Phosphatidylcholine (Soy) (50 mg) (INTERNATIONAL COLD CHAIN SHIPMENTREQUIRED)

1544519

Piroxicam Related Compound A (50 mg) (Pyridin-2-amine)

R168D0F102D0(2024/8)

1554910Prednicarbate Related Compound A (20 mg) (1,2-Dihydroprednicarbate)

R195N0F0F173(2024/8)

1578612

Protamine Sulfate (2.69 mg)

R148E0

R148D0(2024/8)

1598097

Racepinephrine Hydrochloride (100 mg)

R165M0F070V1(2024/8)

1604905

Rocuronium Bromide (250 mg) (COLD SHIPMENT REQUIRED)R165U0R118J0(2024/8)

1611900

Selegiline Hydrochloride (200 mg)

R171D0

R045W0(2024/8)

R176F0R05470(2024/8)

R174H0

H1L048(2024/8)

R165Y0F007L0(2024/8)

R17420

R09700(2024/8)

16125171614669
1642031

Sertraline Hydrochloride Racemic Mixture (30 mg) ((1RS,4RS)-4-(3,4-Dichlorophenyl)-Nmethyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride)
Sodium Starch Glycolate Type A (400 mg)
Sulindac Related Compound C (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4(methylthio)benzylidene]-1H-inden-3-yl}acetic acid)1642813

Tacrolimus Related Compound A (15 mg) (See USP Certificate for full Chemical Name)

1643361

Taurine (100 mg)

R17250

R077A0(2024/8)

1647001

Testosterone Cypionate CIII (200 mg)

R186D0R07480(2024/8)

1650028

Tetracaine Related Compound C (25 mg) (Methyl 4-(butylamino)benzoate)

R158M0F016P0(2024/8)

1680685

Tributyl Phosphine Oxide (25 mg)

R12910

R092V0(2024/8)

USP通知事項

2024年8月

以下の標準品の旧ロットは、2024年9月で有効期限が切れます。
現行ロット

旧ロット

（新ロット）

有効期限(年/月)

Catalog #Description

1021000

Aminocaproic Acid (200 mg)

R18000R09420(2024/9)

1025715

Aminolevulinic Acid Hydrochloride (200 mg)

F013Q1

F013Q0(2024/9)

1031401

Amoxapine (200 mg)

R202U0R000B0(2024/9)

R192N0

R051S0(2024/9)

R18140F042K0(2024/9)

R168S0

R009R0(2024/9)

R17110R06401(2024/9)

Amoxicillin Related Compound D (50 mg) ((4S)-2-{[(R)-2-amino-2-(41031547

hydroxyphenyl)acetamido](carboxy)methyl}-5,5-dimethylthiazolidine-4-carboxylic acid,monosodium salt)

1133853

Cidofovir (100 mg)

1134051

Cilastatin Ammonium Salt (100 mg)

1134211

Cladribine Related Compound A (20 mg) (2-methoxy-2'-deoxyadenosine)
Clomiphene Related Compound A (25 mg) ((E,Z)-2-[4-(1,2-Diphenylethenyl)phenoxy]-

1140101

N,N-diethylethanamine hydrochloride)

R12300(2024/9)

1140666

Cloprostenol Sodium (400 mg)

R173L0F0H392(2024/9)

1150502

Cromolyn Sodium (500 mg)

R166N0

R099H0(2024/9)

1158504

Cyclosporine (50 mg)

R173H0R10770(2024/9)

1254031

Estradiol Valerate Identification Mixture (15 mg)

R171F0F056U0(2024/9)

1268502

Etidronate Disodium (200 mg) (PLANNED TO BE DISCONTINUED)

1269185

Famciclovir Related Compound B (20 mg) (4-(2-Amino-9H-purin-9-yl)-2-

R18010R06220(2024/9)

R190L0

R047E1(2024/9)

F1M370F0M370(2024/9)

R176K0

R092W0(2024/9)

12708211279019
1279826

Flecainide Related Compound A (75 mg) (3-[2,5-Bis(2,2,2-trifluoroethoxy)phenyl]1,5,6,7,8,8alpha-hexahydroimidazo-[1,5alpha]pyridine hydrochloride)
Fluorouracil Related Compound A (25 mg) (Pyrimidine-2,4,6(1H,3H,5H)-trione)
Fluoxetine Related Compound B (5 mL of a 0.01N HCl Solution, approx. 2 mg/mL) (NMethyl-3-phenylpropan-1-amine)G(2024/9)

1289003

Gentamicin Sulfate (200 mg)

R17130

R084Q0(2024/9)

1295724

Glyceryl Distearate (500 mg)

R19880F0F284(2024/9)

R185L0

R118T0(2024/9)

R185A0F036K0(2024/9)

13030241370724

Haloperidol Related Compound B (10 mg) (4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1yl]-1-(2-fluorophenyl)butan-1-one)
Lufenuron Related Compound B (15 mg) (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]2,6-difluorobenzamide)

1733119

Meso-Zeaxanthin (5x 30 mg)

R184A0F0K295(2024/9)

1445550

Monoclonal IgG System Suitability (2 mg) (COLD SHIPMENT REQUIRED)

R169P0F007G0(2024/9)

1530004

Phentolamine Mesylate (200 mg)

R21440

R087H0(2024/9)

1569315

Pimobendan (100 mg)

R186S0F04860(2024/9)

1545409

Polacrilex Resin (100 mg) (Methacrylic acid polymer with divinylbenzene)

R158L0

F2D233(2024/9)

1546922Polyethylene Terephthalate G (PETG) (3 Strips 2''x2'' each)

R18470F1H430(2024/9)

1547969

Polysorbate 80 (4 x 0.5 g)

R183E0

R072G0(2024/9)

1355709

Powdered Kava Extract (1 g)

1553000

Pralidoxime Chloride (200 mg)

R172N0R118A0(2024/9)

1572536

Propofol Related Compound A (25 mg) (3,3',5,5'-Tetraisopropylbiphenyl-4,4'-diol)

R172S0

R004R0(2024/9)

1576785

Propylene Glycol Monolaurate Type I (500 mg)

R190Y0F0E202(2024/9)

1583805

Pygeum Extract (150 mg)

R190N0F0F286(2024/9)

R21800

R044J0(2024/9)

R193V0F074Y1(2024/9)

R211K0F0I090(2024/9)

R188Q0F15190(2024/9)

R08121

R08120(2024/9)

R165Q0F0I366(2024/9)

F0C161(2024/9)

Risedronate Related Compound B (20 mg) ([3,6-Bis[(3-pyridinyl)methyl]-2,5-dihydroxy1604632

2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium
tetrahydrate salt)

16127651667155
166762116990051725014Sirolimus (50 mg)
Ticlopidine Related Compound A (20 mg) (4-oxo-4,5,6,7-tetrahydrothieno-[3,2c]pyridine)
Tiotropium Related Compound G (50 mg) ((1R,2R,4S,5S,7s)-7-Hydroxy-9,9-dimethyl-3oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide)
Tropicamide (200 mg)
Zonisamide Related Compound A (20 mg) (1,2-benzisoxazole-3-methanesulfonic acidsodium salt)